A Comparison of Real-World Treatment Patterns and Clinical Outcomes in Patients Receiving First-Line Therapy for Unresectable Advanced Gastric or Gastroesophageal Junction Cancer Versus Esophageal Adenocarcinomas

INTRODUCTION: Management of locally advanced, unresectable, or metastatic (adv/met) esophageal adenocarcinoma (EAC) follows clinical guidance for gastric cancer (GC) and gastroesophageal junction cancer (GEJC). However, evidence for these guidelines is based largely on patients with adv/met GC/GEJC,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Adv Ther
Hoofdauteurs: Shankaran, Veena, Xiao, Hong, Bertwistle, David, Zhang, Ying, You, Min, Abraham, Pranav, Chau, Ian
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Healthcare 2020
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7854438/
https://ncbi.nlm.nih.gov/pubmed/33244736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01567-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items